Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
16.17
+0.49 (3.13%)
Apr 28, 2025, 4:00 PM EDT - Market closed

Denali Therapeutics Stock Forecast

Stock Price Forecast

The 13 analysts with 12-month price forecasts for Denali Therapeutics stock have an average target of 38, with a low estimate of 24 and a high estimate of 87. The average target predicts an increase of 135.00% from the current stock price of 16.17.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $24 $38 $35 $87
Change +48.42% +135.00% +116.45% +438.03%
* Price targets were last updated on Mar 10, 2025.

Analyst Ratings

The average analyst rating for Denali Therapeutics stock from 15 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Nov '24Dec '24Jan '25Feb '25Mar '25Apr '25
Strong Buy 677787
Buy 335577
Hold 211111
Sell 000000
Strong Sell 000000
Total 111113131615

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
B of A Securities
B of A Securities
Strong Buy
Maintains
$30$28
Strong Buy Maintains $30$28 +73.16% Mar 10, 2025
Morgan Stanley
Morgan Stanley
Buy
Initiates
$41$33
Buy Initiates $41$33 +104.08% Mar 7, 2025
B. Riley Securities
B. Riley Securities
Strong Buy
Reiterates
$38$35
Strong Buy Reiterates $38$35 +116.45% Mar 5, 2025
Oppenheimer
Oppenheimer
Buy
Maintains
$50$42
Buy Maintains $50$42 +159.74% Mar 3, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$80$87
Strong Buy Maintains $80$87 +438.03% Feb 28, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
23.65M
Revenue Next Year
114.51M
from 23.65M
Increased by 384.25%
EPS This Year
-2.89
from -2.57
EPS Next Year
-2.74
from -2.89
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
335.66M48.66M108.46M330.53M-23.65M114.51M276.06M
Revenue Growth
1,158.19%-85.50%122.90%204.74%--384.25%141.08%
EPS
0.63-2.39-2.60-1.06-2.57-2.89-2.74-2.41
EPS Growth
--------
Forward PE
--------
No. Analysts
-----201915
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 131.3M 298.3M 820.0M
Avg 23.6M 114.5M 276.1M
Low n/a 24.8M 105.8M

Revenue Growth

Revenue Growth 20252026202720282029
High -
1,161.6%
616.1%
Avg -
384.2%
141.1%
Low -
5.0%
-7.6%

EPS Forecast

EPS 20252026202720282029
High -2.30 -1.73 -0.87
Avg -2.89 -2.74 -2.41
Low -3.26 -3.57 -3.31

EPS Growth

EPS Growth 20252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.